Skip to content
Open access

Dissecting the transcriptome of Parkin (PRKN)-linked Parkinson’s disease using 2D and 3D hiPSC-neuronal models

Jul 2026 · Communications Biology · 0 citations

TL;DR

This work generates human induced pluripotent stem cell-derived midbrain dopaminergic neurons using both a 2D differentiation protocol and a recently developed 3D method based on the microencapsulation of hiPSCs in small alginate/fibronectin beads.

Abstract

Mutations in the Parkin ( PRKN ) gene are the most common known cause of autosomal recessive early-onset Parkinson’s disease (PD), and Parkin dysfunction represents a risk factor for idiopathic PD. Parkin is an E3 ubiquitin ligase, involved in protein quality control and the removal of damaged mitochondria. Here, we generate human induced pluripotent stem cell (hiPSC)-derived midbrain dopaminergic neurons using both a 2D differentiation protocol and our recently developed 3D method based on the microencapsulation of hiPSCs in small alginate/fibronectin beads. The transcriptional signature of cells from PD patients carrying PRKN mutations is evaluated at the neuronal stage and during the differentiation process. Analyses of mutation-specific gene sets and associated pathways reveal multiple biological processes implicated in PRKN -pathology, including synaptic and metabolic function, inflammation, and intracellular trafficking, reflecting a layered disease development. These data map the contribution of Parkin in early PD pathogenesis and progression before overt neurodegeneration.

Read PDF

Similar papers

Open access Jul 2026

The human LRRK2-R1441G mutation drives age-dependent oxidative stress and mitochondrial dysfunction in dopaminergic neurons.

Findings reveal an age-dependent progression of mitochondrial dysfunction in BAC-hR1441G SNc DA neurons, and dysregulation of calcium channels and uncoupling proteins emerges as a key mechanism contributing to bioenergetic failure, suggesting potential therapeutic targets to mitigate PD progression.

Yuanxin Chen, Lianteng Zhi, Shiquan Cui et al. · 1 citation
Open access Aug 2026

Mitochondrial Metabolism and Calcium Handling in Parkinson’s Disease hiPSC-derived Astrocytes

Astrocyte-specific mitochondrial dysfunctions and calcium dysregulation are identified as key features of LRRK2- and PRKN-related pathology, providing new insights into how glial metabolic alterations contribute to neurodegeneration in PD.

Giovanna C. Cavalcante, C. C. Caldeira da Silva, É. Vogt et al. · 0 citations
Open access Jul 2026

Neurogenesis defects in iPSC-derived midbrain organoids of early-onset Parkinson's disease with 22q11.2 deletion syndrome

These findings suggest that, in early-onset PD patients with 22q11.2 DS or PRKN mutation, enhanced neurogenesis could result in reduced number of dopaminergic neurons during early development, which indicates that the onset of PD may occur as early as the embryonic stage.

Syugo Ueki, Toshiya Kimura, Rie Tohge et al. · 0 citations
Open access Jul 2026

Modeling Parkinson’s pathology in human iPSC dopaminergic neurons uncovers key mechanisms of Lewy body formation and heterogeneity

A human isogenic induced pluripotent stem cell–derived dopaminergic neuron (iDA) model is presented that faithfully recapitulates the diverse biochemical, morphological, and ultrastructural features of LB neuropathology and provides critical insight into how different pathways to aSyn fibrillization and the complex int...

Anne-Laure Mahul-Mellier, Lukas van den Heuvel, Maxime Teixeira et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.